Skip to main content
Article thumbnail
Location of Repository

Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormones-sensitive lipase in human subcutaneous abdominal adipocytes

By S. L. Palin, P. G. McTernan, K. C. McGee, D. W. Sturdee, A. H. Barnett and Sudhesh Kumar

Abstract

Aim: In premenopausal women, hyper-androgenicity is associated with central obesity and an increased cardiovascular risk. We investigated the effects of dydrogesterone (DYD)(a non-androgenic progestogen) and norethisterone (NET)(an androgenic progestogen) on lipoprotein lipase (LPL), hormone-sensitive lipase (HSL) and glycerol release in adipocytes isolated from subcutaneous abdominal adipose tissue. Methods: Adipose tissue was obtained from 12 non-diabetic women, mean age 51 years (range 37-78) and mean BMI 25.4kg/m2 (range 20.3-26.4). Adipocytes were treated with increasing doses of DYD and NET for 48 hours prior to protein extraction. Effects on lipogenesis and lipolysis were assessed using western blotting to determine the expression of key enzymes, LPL (56kDa) and HSL (84kDa) respectively. Measurement of glycerol release into the medium provided an assessment of lipolytic activity. Results: Expression of LPL was increased by DYD and NET (mean protein expression relative to control ± SEM); with greatest effect at 10-8M for DYD: 2.32±0.51(p<0.01) and 10-8M for NET: 2.06±0.19(p<0.01). In contrast, HSL expression was reduced by all concentrations of DYD, with maximal effect at 10-9M: 0.49±0.02(p<0.001). NET reduced HSL expression at all concentrations from 10-9M: 0.62±0.06(p<0.001) to 10-7M: 0.69±0.08(p<0.001). Glycerol measurements supported the HSL expression studies(p>0.05). Conclusions: DYD and NET significantly increased LPL expression relative to control whilst significantly reducing HSL expression. At the concentrations studied, similar effects were observed with the androgenic NET and the non-androgenic DYD despite differing effects on the lipid profile when taken\ud in combination with estrogen. Further work in this area may improve knowledge about the effects of different progestogens on body fat distribution and enable progestogen use to be tailored to the individual to achieve maximal benefits

Topics: RM
Publisher: Blackwell
Year: 2007
OAI identifier: oai:wrap.warwick.ac.uk:143

Suggested articles

Citations

  1. (2003). 17β-estradiol and anti-estrogen ICI: compound 182,780 regulate expression of lipoprotein lipase and hormone-sensitive lipase in isolated subcutaneous abdominal adipocytes. Metabolism doi
  2. (1992). and menopause-associated changes in body-fat distribution. doi
  3. (1993). Associations of hormone replacement therapy with various cardiovascular risk factors for post-menopausal women. doi
  4. (1982). Comparison of pharmacodynamic properties of various estrogen formulations.
  5. (1998). Concentration of sex steroid in adipose tissue after menopause. Steroids doi
  6. (1980). Cytoplasmic estrogen, but not progestin, binding sites in male rat adipose tissues.
  7. (1993). Determination of estrogen receptor messenger ribonucleic acid (mRNA) and cytochrome P450 aromatase mRNA levels in adipocytes and adipose stromal cells by competitive polymerase chain reaction amplification. doi
  8. (1998). Differential impact of conventional oral or transdermal hormone replacement therapy or tibolone on body composition in postmenopausal women. Clin Endocrinol doi
  9. (1984). Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women doi
  10. (1983). Effect of local application of progesterone on human adipose tissue lipoprotein lipase. Horm Metabol Res doi
  11. (1981). Effect of progesterone on lipid metabolism in the intact rat. doi
  12. (1986). Effects of 2-fluoroestradiol on lipid metabolism in the ovariectomized rat. doi
  13. (2000). Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal women. Menopause doi
  14. (1978). Effects of ethynyl estradiol and progesterone on triglyceride metabolism in the female rat. Endocrinol doi
  15. (1985). Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer. Horm Metabol Res doi
  16. (1991). Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women. doi
  17. (1995). Effects of hormone replacement therapy on weight, body composition, fat distribution, and food intake in early postmenopausal women: a prospective study. Fertil Steril
  18. (1991). Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. doi
  19. (2001). Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000. Fertil Steril doi
  20. (1987). Effects of sex steroid hormones on differentiation of adipose precursor cells in primary culture. Exp Cell Res doi
  21. (1988). Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation doi
  22. (1984). Enhancement in cholesterolesterase activity and lipolysis due to 17ß-estradiol treatment in rat adipose tissue. Horm Metabol Res doi
  23. (1998). Estrogen regulation of adipose tissue lipoprotein lipase - Possible mechanism of body fat distribution. doi
  24. (1981). Food intake, body weight, and adiposity in female rats: actions and interactions of progestins and antiestrogens.
  25. (2000). Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. doi
  26. (1980). Hormonal modulation of adipose tissue lipoprotein lipase may alter food intake in rats.
  27. (1995). Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol doi
  28. (1998). Identification of Progesterone Receptor in Human Subcutaneous Adipose Tissue. doi
  29. (1989). Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA doi
  30. (1991). Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism doi
  31. (1996). Progesterone and dexamethasone stimulate proliferation and differentiation of osteoprogenitors and progenitors for adipocytes and macrophages in cell populations derived from adult rat vertebrae. doi
  32. (1996). Progestins: Present and Future.
  33. (1987). Regional adipose tissue metabolism in men and postmenopausal women. doi
  34. (1990). Regional adipose tissue metabolism in postmenopausal women after treatment with exogenous sex steroids. Horm Metabol Res doi
  35. (1988). Relationship between lipoprotein lipase activity and plasma sex steroid levels in obese women. doi
  36. (1983). Relationship of androgenic activity to body fat topography, fat cell morphology, and metabolic abberations in premenopausal women. doi
  37. (1982). Relationships between chemical structure and biological properties of progestogens.
  38. (1987). Sex steroid hormones and adipose tissue metabolism in ovariectomized and adrenalectomized rats. Acta Physiol Scand doi
  39. (1975). Sex steroid influence on triglyceride metabolism. doi
  40. (1975). The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. doi
  41. (1992). The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
  42. (1995). The Writing Group for the PEPI Trial. Effects of estrogen/progestin regimens on heart disease risk factors in post-menopausal women. doi
  43. (1994). Tumour necrosis factor increases the rate of lipolysis in primary cultures of adipocytes by a novel mechanism. Endocrinology doi
  44. (1990). Visceral fat accumulation in men is positively associated with insulin, glucose and C-peptide levels, but negatively with testosterone levels. Metabolism doi
  45. (2000). Weight gain and hormone replacement therapy: are women's fears justified? Maturitas doi

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.